Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Prostate Cancer, Castration Resistant”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT04580485
What this trial is testing

INCB106385 Alone or in Combination With Immunotherapy in Advanced Solid Tumors

Who this might be right for
Ovarian CancerBladder CancerNon Small Cell Lung Cancer+8 more
Incyte Corporation 54
Not applicableLooking for participantsNCT06659926
What this trial is testing

The Radium-select Study

Who this might be right for
mCRPCMale Urogenital Diseases
The Netherlands Cancer Institute 60
Testing effectiveness (Phase 2)Study completedNCT02025010
What this trial is testing

Study of Abiraterone Acetate Without Exogenous Glucocorticoids in Men With Castration-resistant Prostate Cancer

Who this might be right for
Castration-resistant Prostate Cancer
Dana-Farber Cancer Institute 60
Very early researchUnknownNCT02691169
What this trial is testing

Integrated 18F-labelled PSMA Project

Who this might be right for
Prostate Cancer
St. Joseph's Healthcare Hamilton 10
Testing effectiveness (Phase 2)Active Not RecruitingNCT03517969
What this trial is testing

M6620 and Carboplatin With or Without Docetaxel in Treating Patients With Metastatic Castration-Resistant Prostate Cancer

Who this might be right for
Castration-Resistant Prostate CarcinomaMetastatic Prostate CarcinomaStage IV Prostate Cancer AJCC v8
National Cancer Institute (NCI) 73
Not applicableLooking for participantsNCT06242509
What this trial is testing

Intestinal Akkermansia Muciniphila in Prostate Cancer

Who this might be right for
Metastatic Castration-resistant Prostate Cancer
Assistance Publique - Hôpitaux de Paris 52
Not applicableStudy completedNCT03328364
What this trial is testing

A Registry Based Study Evaluating Overall Survival and Treatment Length in mCRPC Patients Treated With Enzalutamide in Sweden

Who this might be right for
Metastatic Castration Resistant Prostate Cancer
Astellas Pharma a/s 211
Large-scale testing (Phase 3)Study completedNCT03834519
What this trial is testing

Study of Pembrolizumab (MK-3475) Plus Olaparib Versus Abiraterone Acetate or Enzalutamide in Metastatic Castration-resistant Prostate Cancer (mCRPC) (MK-7339-010/KEYLYNK-010)

Who this might be right for
Prostatic Neoplasms
Merck Sharp & Dohme LLC 793
Early research (Phase 1)Ended earlyNCT02995330
What this trial is testing

Sex-Mismatched Allogeneic Bone Marrow Transplantation for Men With Metastatic Castration-Resistant Prostate Cancer

Who this might be right for
Prostate Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 3
Testing effectiveness (Phase 2)Study completedNCT01685268
What this trial is testing

HSP90 Inhibitor AT13387 Alone or in Combination With Abiraterone Acetate

Who this might be right for
Prostate Cancer
Astex Pharmaceuticals, Inc. 49
Early research (Phase 1)WithdrawnNCT01685489
What this trial is testing

A Phase 1b Dose Escalation Trial of PSK®/Placebo With Docetaxel to Treat Metastatic Castration-resistant Prostate Cancer

Who this might be right for
Prostatic Neoplasms
Bastyr University
Early research (Phase 1)Study completedNCT02339168
What this trial is testing

Enzalutamide and Metformin Hydrochloride in Treating Patients With Hormone-Resistant Prostate Cancer

Who this might be right for
Prostate Cancer
University of California, Davis 25
Post-approval studies (Phase 4)Study completedNCT01649635
What this trial is testing

Study of Cabazitaxel Combined With Prednisone and Prophylaxis of Neutropenia Complications in the Treatment of Patients With Metastatic Castration-resistant Prostate Cancer

Who this might be right for
Prostate Cancer
Sanofi 45
Early research (Phase 1)Ended earlyNCT05673109
What this trial is testing

AC176 for the Treatment of Metastatic Castration Resistant Prostate Cancer

Who this might be right for
Metastatic Castration Resistant Prostate Cancer
Accutar Biotechnology Inc 8
Early research (Phase 1)Ended earlyNCT04726332
What this trial is testing

Study of XL102 as Single-Agent and Combination Therapy in Subjects With Solid Tumors (QUARTZ-101)

Who this might be right for
Neoplasm MalignantEpithelial Ovarian CancerTriple Negative Breast Cancer+2 more
Exelixis 52
Large-scale testing (Phase 3)Study completedNCT02200614
What this trial is testing

Efficacy and Safety Study of Darolutamide (ODM-201) in Men With High-risk Non-metastatic Castration-resistant Prostate Cancer

Who this might be right for
Prostate Cancer Non-MetastaticCastration-Resistant
Bayer 1,509
Testing effectiveness (Phase 2)Ended earlyNCT01335204
What this trial is testing

Ph Ib/IIa Study of Cabazitaxel Plus Bavituximab in Castration-resistant Prostate Cancer

Who this might be right for
Prostate CancerProstatic Neoplasms
Medical University of South Carolina 4
Early research (Phase 1)Study completedNCT01162395
What this trial is testing

Open Label Prostate Cancer Study

Who this might be right for
Prostate Cancer
AstraZeneca 64
Early research (Phase 1)Ended earlyNCT02911467
What this trial is testing

Magnetic Resonance (MR) Imaging With Hyperpolarized Pyruvate (HP) (13C) in Castration-Resistant Prostate Cancer

Who this might be right for
Prostate Cancer
Rahul Aggarwal 8
Very early researchUnknownNCT03960788
What this trial is testing

Gadoxetate Sodium Enhanced MRI as a Biomarker for Aggressive Prostate Cancer

Who this might be right for
Cancer of the ProstateCastration-resistant Prostate Cancer
University of Cincinnati 50
Next Page